After working at large Contract Research Organizations (CROs) Atlantic Research Group's management have seen that small and mid-size pharmaceutical companies were not receiving the same quality of clinical drug development services as larger companies. It was the goal of filling this void that led to the formation of Atlantic Research Group, Inc. And it is this vision that continues to guide the company on a daily basis.

Since its inception, ARG has become a preferred clinical trial management provider for several emerging biopharmaceutical companies. This position was earned by the focus, passion and total commitment of the entire ARG team.

Paul Bishop, Managing Partner

Prior to co-founding Atlantic Research Group, Paul served in a clinical management role at a large global CRO. He has also held positions at other large and mid-sized CROs in clinical operations. He has experience in oncologic, metabolic disease and ophthalmologic development programs both in clinical operations and business development. He is also on the senior management team of the Atlantic Research Network (ARN). Paul graduated from the University of Virginia with a degree in biology.

Lyle Camblos, Managing Partner

Prior to co-founding Atlantic Research Group, Lyle served as a clinical project manager and various other lead clinical roles for a large and mid-sized CRO. He has experience in oncology, immunology, and inflammatory disease indications. Lyle serves as ARG's project management development chair and is also on the senior management team of the Atlantic Research Network (ARN). Lyle graduated from the Virginia Military Institute with a degree in economics.

Hunter Walker, Vice President, Clinical Systems

Hunter joined ARG in 2006 and is the chief architect of TrialVista®, a proprietary clinical trial management system (CTMS) that tracks, measures, and reports on every aspect of a clinical trial. Prior to joining ARG Hunter served as a clinical technology developer with a large CRO and a small biotechnology company in San Diego. Currently he is responsible for the strategic development of TrialVista and is a leader in the software-as-a-service platform for clinical trial management. In addition, Hunter serves as the Chief Technology Officer for the Atlantic Research Network (ARN). Hunter graduated from the University of Virginia with a degree in biology.